Cablevision's support of The Lustgarten Foundation ensures that 100% of every donation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed nearly $110 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2014  |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2009 Research Grants

Cold Spring Harbor Laboratory*
Gregory J. Hannon, Ph.D.
Genetic Approaches to Therapeutic Targets in Pancreatic Cancer

Johns Hopkins University*
Ralph Hruban, M.D.
Sequencing the Familial Pancreatic Cancer Genomes

Mayo Clinic
Fergus Couch, M.D., Ph.D.
Molecular Charaterization of Precursor Lesions in the Pancreas

Memorial Sloan Kettering Cancer Center
Peter Allen, M.D.
Early Detection Project to Develop a Plasma/Cystic Fluid based Test to Detect Pancreatic Cancer

Memorial Sloan Kettering Cancer Center
Scott Lowe, Ph.D.
Investigation of K-ras Effector Pathways in Pancreatic Cancer

University of Texas M.D. Anderson Cancer Center
Rosa F. Hwang, M.D.
Wnt Signaling in Pancreatic Cancer Associated Stroma

The Koch Institute for Integrative Cancer Research at MIT*
Tyler Jacks, Ph.D.
Scott Lowe, Ph.D.
Investigation of K-ras Effector Pathways in Pancreatic Cancer

Columbia University
Thomas Ludwig, Ph.D.
The Role of PALB2/FANCN in the Development of Pancreatic Cancers

Johns Hopkins University
Akhilesh Pandey, M.D., Ph.D.
Kinome Profiling to Identify Novel Therapeutic Targets in Pancreatic Cancer

Johns Hopkins University
Bert Vogelstein, Ph.D.
Early Detection Project to Develop a Plasma/Cystic Fluid Based Test to Detect Pancreatic Cancer
The Development of Novel Diagnostic Approaches for the Early Detection of Pancreatic Neoplasms

Rockefeller University
Ralph Steinman, M.D.
Immunotherapy of Pancreatic Cancer by Targeting Mesothelin to Activated Dendritic Cells in Vivo

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303